DK1799201T3 - 4-Hydroxy-tamoxifen gelformuleringer - Google Patents
4-Hydroxy-tamoxifen gelformuleringerInfo
- Publication number
- DK1799201T3 DK1799201T3 DK05803579T DK05803579T DK1799201T3 DK 1799201 T3 DK1799201 T3 DK 1799201T3 DK 05803579 T DK05803579 T DK 05803579T DK 05803579 T DK05803579 T DK 05803579T DK 1799201 T3 DK1799201 T3 DK 1799201T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydroxy
- gel formulations
- tamoxifen gel
- tamoxifen
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04292447A EP1647271A1 (en) | 2004-10-14 | 2004-10-14 | 4-Hydroxy tamoxifen gel formulations |
| US63835904P | 2004-12-23 | 2004-12-23 | |
| PCT/EP2005/011654 WO2006040196A1 (en) | 2004-10-14 | 2005-10-13 | 4-hydroxy tamoxifen gel formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1799201T3 true DK1799201T3 (da) | 2009-03-30 |
Family
ID=35501209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05803579T DK1799201T3 (da) | 2004-10-14 | 2005-10-13 | 4-Hydroxy-tamoxifen gelformuleringer |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1799201B1 (da) |
| JP (1) | JP5047800B2 (da) |
| KR (1) | KR101294947B1 (da) |
| AT (1) | ATE415156T1 (da) |
| AU (1) | AU2005293712B2 (da) |
| BR (1) | BRPI0518139B1 (da) |
| CA (1) | CA2582174C (da) |
| CY (1) | CY1110499T1 (da) |
| DE (1) | DE602005011314D1 (da) |
| DK (1) | DK1799201T3 (da) |
| EA (1) | EA011295B1 (da) |
| ES (1) | ES2318563T3 (da) |
| GE (1) | GEP20104889B (da) |
| HK (1) | HK1103027A1 (da) |
| HR (1) | HRP20090239T1 (da) |
| IL (1) | IL182298A (da) |
| MA (1) | MA28927B1 (da) |
| MX (1) | MX2007004371A (da) |
| NO (1) | NO338755B1 (da) |
| PL (1) | PL1799201T3 (da) |
| PT (1) | PT1799201E (da) |
| SI (1) | SI1799201T1 (da) |
| TN (1) | TNSN07139A1 (da) |
| WO (1) | WO2006040196A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10080760B2 (en) * | 2009-10-27 | 2018-09-25 | Besins Healthcare Luxembourg Sarl | Transdermal pharmaceutical compositions comprising active agents |
| KR101304536B1 (ko) * | 2011-06-03 | 2013-09-24 | 전남대학교산학협력단 | 4-하이드록시 타목시펜 유사체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 간질환의 치료 또는 예방용 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2558373B1 (fr) * | 1984-01-20 | 1987-07-03 | Mauvais Jarvis Pierre | Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee |
| JP4938237B2 (ja) * | 2002-12-18 | 2012-05-23 | ラボラトワール ブザン アンテルナスィヨナル | ４−ヒドロキシタモキシフェンによる乳房痛の治療 |
| EP1952809B1 (en) * | 2002-12-18 | 2017-08-02 | Besins Healthcare Luxembourg SARL | Formulations for the reduction of breast density with 4-Hydroxy Tamoxifen |
| JP5490346B2 (ja) * | 2003-04-01 | 2014-05-14 | ブザン ヘルスケア ルクセンブルグ エスアーエールエル | ４−ヒドロキシタモキシフェンによる乳癌の予防および治療 |
| JP5069469B2 (ja) * | 2003-12-15 | 2012-11-07 | ラボラトワール ブザン アンテルナスィヨナル | 女性化乳房治療用の薬剤を製造する際の４−ヒドロキシタモキシフェンの使用 |
| EP1579856A1 (en) * | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| AU2005227072B2 (en) * | 2004-03-22 | 2010-08-19 | Besins Healthcare Luxembourg Sarl | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US20050208139A1 (en) * | 2004-03-22 | 2005-09-22 | Ascend Therapeutics, Inc. | Chemically stable compositions of 4-hydroxy tamoxifen |
-
2005
- 2005-10-13 DK DK05803579T patent/DK1799201T3/da active
- 2005-10-13 SI SI200530597T patent/SI1799201T1/sl unknown
- 2005-10-13 WO PCT/EP2005/011654 patent/WO2006040196A1/en active Application Filing
- 2005-10-13 DE DE602005011314T patent/DE602005011314D1/de active Active
- 2005-10-13 AT AT05803579T patent/ATE415156T1/de active
- 2005-10-13 ES ES05803579T patent/ES2318563T3/es active Active
- 2005-10-13 MX MX2007004371A patent/MX2007004371A/es active IP Right Grant
- 2005-10-13 PL PL05803579T patent/PL1799201T3/pl unknown
- 2005-10-13 CA CA2582174A patent/CA2582174C/en active Active
- 2005-10-13 PT PT05803579T patent/PT1799201E/pt unknown
- 2005-10-13 GE GEAP20059987A patent/GEP20104889B/en unknown
- 2005-10-13 AU AU2005293712A patent/AU2005293712B2/en active Active
- 2005-10-13 EP EP05803579A patent/EP1799201B1/en active Active
- 2005-10-13 JP JP2007536126A patent/JP5047800B2/ja active Active
- 2005-10-13 KR KR1020077008384A patent/KR101294947B1/ko active IP Right Grant
- 2005-10-13 EA EA200700834A patent/EA011295B1/ru unknown
- 2005-10-13 BR BRPI0518139-9A patent/BRPI0518139B1/pt active IP Right Grant
-
2007
- 2007-03-29 IL IL182298A patent/IL182298A/en active IP Right Grant
- 2007-04-09 MA MA29815A patent/MA28927B1/fr unknown
- 2007-04-13 TN TNP2007000139A patent/TNSN07139A1/fr unknown
- 2007-05-14 NO NO20072463A patent/NO338755B1/no unknown
- 2007-10-18 HK HK07111311.2A patent/HK1103027A1/xx unknown
-
2009
- 2009-02-20 CY CY20091100201T patent/CY1110499T1/el unknown
- 2009-04-22 HR HR20090239T patent/HRP20090239T1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA011295B1 (ru) | 2009-02-27 |
| CA2582174C (en) | 2013-01-29 |
| PL1799201T3 (pl) | 2009-05-29 |
| DE602005011314D1 (de) | 2009-01-08 |
| ES2318563T3 (es) | 2009-05-01 |
| GEP20104889B (en) | 2010-02-10 |
| EA200700834A1 (ru) | 2007-10-26 |
| AU2005293712B2 (en) | 2011-04-21 |
| EP1799201A1 (en) | 2007-06-27 |
| SI1799201T1 (sl) | 2009-06-30 |
| NO338755B1 (no) | 2016-10-17 |
| JP2008525316A (ja) | 2008-07-17 |
| KR20070068366A (ko) | 2007-06-29 |
| WO2006040196A1 (en) | 2006-04-20 |
| BRPI0518139A (pt) | 2008-10-28 |
| NO20072463L (no) | 2007-05-14 |
| AU2005293712A1 (en) | 2006-04-20 |
| IL182298A0 (en) | 2007-07-24 |
| HK1103027A1 (en) | 2007-12-14 |
| PT1799201E (pt) | 2009-02-26 |
| ATE415156T1 (de) | 2008-12-15 |
| IL182298A (en) | 2013-01-31 |
| MX2007004371A (es) | 2007-06-07 |
| JP5047800B2 (ja) | 2012-10-10 |
| MA28927B1 (fr) | 2007-10-01 |
| EP1799201B1 (en) | 2008-11-26 |
| BRPI0518139B1 (pt) | 2021-10-13 |
| TNSN07139A1 (en) | 2008-11-21 |
| HRP20090239T1 (en) | 2009-06-30 |
| CA2582174A1 (en) | 2006-04-20 |
| KR101294947B1 (ko) | 2013-08-09 |
| CY1110499T1 (el) | 2015-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20091976L (no) | Nye forbindelser | |
| IL249263A0 (en) | Methods and systems for extracorporeal organ treatment | |
| ATE432067T1 (de) | Embolie-teilchen | |
| SE0301653D0 (sv) | Novel compounds | |
| HRP20080564T3 (en) | Dihydrotetrabenazines and pharmaceutical compositions containing them | |
| UA87335C2 (en) | Gel composition of 4-hydroxytamoxifen | |
| ATE528989T1 (de) | Kristalline feste rasagilin-base | |
| DK1644348T3 (da) | Epoxy-afsluttede polythioethere, Epoxy-afsluttede polythioethere | |
| MXPA05003730A (es) | Eritropoyetina: remodelado y glicoconjugacion de eritropoyetina. | |
| EA200701918A1 (ru) | Белок липокалин | |
| NO20080991L (no) | Bazedoksifen acetat formuleringer | |
| DE502006005053D1 (de) | Spritzbare akustikmassen | |
| EA200601596A1 (ru) | Улучшенный состав 6-меркаптопурина | |
| NO20063293L (no) | Farmasoytiske forbindelser | |
| DE602005009681D1 (de) | Haarbehandlungszusammensetzungen mit einem disaccharid; einer disäure und einer ammoniumionen-quelle | |
| MX2007002917A (es) | Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma. | |
| EA200700023A1 (ru) | Разрыхляющаяся при пероральном приёме фармацевтическая композиция, содержащая рисперидон | |
| ITMI20030385A1 (it) | Composizione cosmetica comprendente poliisoprene. | |
| DK1799201T3 (da) | 4-Hydroxy-tamoxifen gelformuleringer | |
| EA200700580A1 (ru) | Тестостероновые гели, включающие пропиленгликоль в качестве усилителя проницаемости | |
| ATE425212T1 (de) | Tocopherolzusammensetzungen und verwendung | |
| EA200601117A1 (ru) | Малеат ибопамина, способ его получения и фармацевтические композиции на его основе | |
| EA200501059A1 (ru) | Способ защиты кожи | |
| EA200701201A1 (ru) | Новая фармацевтическая композиция для вакцин | |
| BRPI0501052A (pt) | composição cosmética à base de papaìna |